UT MD Anderson Cancer Center /ID# 202271 — Houston, Texas

UT MD Anderson Cancer Center /ID# 202271 is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

UT MD Anderson Cancer Center /ID# 202271 has participated in 1 clinical trials.

Therapeutic areas: Exocrine Pancreatic Insufficiency (EPI).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UT MD Anderson Cancer Center /ID# 202271?

UT MD Anderson Cancer Center /ID# 202271 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UT MD Anderson Cancer Center /ID# 202271 conducted?

UT MD Anderson Cancer Center /ID# 202271 has 1 clinical trials on record. Their work covers Exocrine Pancreatic Insufficiency (EPI).

Is UT MD Anderson Cancer Center /ID# 202271 accredited by Crixeo Health?

UT MD Anderson Cancer Center /ID# 202271 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UT MD Anderson Cancer Center /ID# 202271?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.